McGuire E J, Lucas J A, Gray R H, de la Iglesia F A
Department of Pathology and Experimental Toxicology, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, MI 48105.
Am J Pathol. 1991 Jul;139(1):217-29.
Structurally diverse lipid-regulating agents induce hepatomegaly, hepatic peroxisome proliferation, and hepatocarcinoma in rats by mechanisms not fully understood. Nevertheless the initial hepatic response is a prompt, florid proliferation of peroxisomes. In investigations reported here, changes in the rat hepatic peroxisome compartment were measured by quantitative microscopy to determine chemical structure requirements that relate to peroxisome proliferation and lipid regulation. Aryloxyalkanoic acids plus amide analogs, and thio, benzimidazole, phenylpiperazine, and oxazole derivatives induced peroxisome proliferation and generally decreased plasma triglyceride and total cholesterol levels. These compounds contain an acidic function or are readily metabolized to a chemical with an acidic function. Substitution of the acidic function with an adamantyloxy eliminated peroxisome proliferation and induced contrasting effects on lipid profile, increasing triglycerides and decreasing total cholesterol. A previously unreported, direct correlation emerged between peroxisome proliferation and plasma high-density lipoprotein-cholesterol levels. These effects could not be elicited separately, negating identification of functional groups that could be associated with either activity. Chemical structure and resulting peroxisome proliferation with changes in plasma lipoproteins are therefore closely interrelated in rats.
结构多样的脂质调节剂可通过尚未完全了解的机制在大鼠中诱发肝肿大、肝过氧化物酶体增殖和肝癌。然而,最初的肝脏反应是过氧化物酶体迅速、旺盛的增殖。在本文报道的研究中,通过定量显微镜测量大鼠肝脏过氧化物酶体区室的变化,以确定与过氧化物酶体增殖和脂质调节相关的化学结构要求。芳氧基链烷酸及其酰胺类似物,以及硫代、苯并咪唑、苯基哌嗪和恶唑衍生物可诱导过氧化物酶体增殖,并普遍降低血浆甘油三酯和总胆固醇水平。这些化合物含有酸性官能团,或易于代谢为具有酸性官能团的化学物质。用金刚烷氧基取代酸性官能团可消除过氧化物酶体增殖,并对脂质谱产生相反的影响,即增加甘油三酯并降低总胆固醇。过氧化物酶体增殖与血浆高密度脂蛋白胆固醇水平之间出现了一种以前未报道的直接相关性。这些效应不能单独引发,这否定了与任何一种活性相关的官能团的鉴定。因此,在大鼠中,化学结构与由此导致的过氧化物酶体增殖以及血浆脂蛋白变化密切相关。